X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (28) 28
humans (26) 26
abridged index medicus (17) 17
female (16) 16
male (16) 16
cardiac & cardiovascular systems (14) 14
middle aged (14) 14
acute coronary syndromes (13) 13
aged (13) 13
cardiovascular (13) 13
heart attacks (11) 11
cardiovascular disease (9) 9
clinical trials (9) 9
double-blind method (9) 9
myocardial infarction (9) 9
adult (8) 8
patients (8) 8
stem cells (8) 8
heart failure (7) 7
myocardial-infarction (7) 7
therapy (7) 7
thrombosis (7) 7
treatment outcome (7) 7
anticoagulants (6) 6
article (6) 6
cardiology (6) 6
coronary vessels (6) 6
heart diseases (6) 6
medical colleges (6) 6
stroke (6) 6
analysis (5) 5
angina (5) 5
biomarkers (5) 5
bone-marrow (5) 5
cardiac patients (5) 5
coronary heart disease (5) 5
follow-up studies (5) 5
internal medicine (5) 5
medical research (5) 5
medicine, experimental (5) 5
medicine, general & internal (5) 5
safety (5) 5
transplantation (5) 5
acute coronary syndrome - drug therapy (4) 4
aged, 80 and over (4) 4
angina pectoris (4) 4
aspirin (4) 4
atherosclerosis (4) 4
cardiology and cardiovascular medicine (4) 4
care and treatment (4) 4
double-blind (4) 4
efficacy (4) 4
endothelium (4) 4
heart failure - therapy (4) 4
hematology (4) 4
ischemia (4) 4
management (4) 4
mortality (4) 4
number (4) 4
peripheral vascular disease (4) 4
prospective studies (4) 4
risk (4) 4
transplantation, autologous (4) 4
ac133 antigen (3) 3
acute myocardial-infarction (3) 3
adenosine - analogs & derivatives (3) 3
aldehyde dehydrogenase - metabolism (3) 3
aptamers, nucleotide - therapeutic use (3) 3
aspirin - administration & dosage (3) 3
bone marrow (3) 3
cardiac catheterization (3) 3
cardiomyopathy (3) 3
cardiovascular system (3) 3
chronic disease (3) 3
clinical outcomes (3) 3
delivery (3) 3
differentiation (3) 3
dose-response relationship, drug (3) 3
drug dosages (3) 3
electrocardiography (3) 3
endothelial cells - metabolism (3) 3
guidelines (3) 3
heart (3) 3
heart attack (3) 3
heart failure - etiology (3) 3
heart failure - physiopathology (3) 3
incidence (3) 3
infarction (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
myocardial infarction - drug therapy (3) 3
myocardium (3) 3
peripheral-blood (3) 3
quality of life (3) 3
research & development--r&d (3) 3
rna (3) 3
rna aptamers (3) 3
stem cell (3) 3
stem cells - cytology (3) 3
stents (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10081, pp. 1799 - 1808
Summary Background Dual antiplatelet therapy (DAPT), aspirin plus a P2Y12 inhibitor, is the standard antithrombotic treatment following acute coronary... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | CLOPIDOGREL | MANAGEMENT | MYOCARDIAL-INFARCTION | TICAGRELOR | STENT THROMBOSIS | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | INTERVENTION | SECONDARY PREVENTION | ANTIPLATELET THERAPY | Purinergic P2Y Receptor Antagonists - administration & dosage | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Myocardial Infarction - diagnostic imaging | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Coronary Angiography - methods | Adenosine - therapeutic use | Thrombolytic Therapy - methods | Ticlopidine - administration & dosage | Female | Myocardial Infarction - physiopathology | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Electrocardiography - methods | Purinergic P2Y Receptor Antagonists - therapeutic use | Rivaroxaban - therapeutic use | Double-Blind Method | Treatment Outcome | Adenosine - administration & dosage | Ticlopidine - analogs & derivatives | Acute Coronary Syndrome - drug therapy | Drug Therapy, Combination - methods | Factor Xa Inhibitors - therapeutic use | Myocardial Infarction - drug therapy | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Medical research | Medical colleges | Aspirin | Mortality | Cardiac patients | Clinical trials | Medicine, Experimental | Dosage and administration | Research institutes | France | Coronary heart disease | Analysis | Myocardial infarction | Therapy | Angiography | Medical services | Disorders | Angina | Bleeding | Elevation | Randomization | Motivation | Atherosclerosis | Safety | Drug therapy | Drug dosages | Heart diseases | Anticoagulants | Research & development--R&D | Strata | Coronary artery | Patients | Thrombosis | Thrombolysis | Inhibitors | Arteriosclerosis | Biomarkers | Infarction | Acute coronary syndromes | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2015, Volume 137, Issue 5, pp. 1610 - 1613.e7
  To the Editor: Nucleic acid aptamers are a novel class of drugs that can be selected to inhibit targets of interest, including protein-protein interactions.1... 
Allergy and Immunology | Antigen-antibody reactions | Viral antibodies | Allergy | RNA | Polyethylene glycol | Antibodies | Research institutes | Cardiology | Allergic reaction | Proteins | Enzymes | Immunoglobulins | Cytokines | Laboratories | Acute coronary syndromes | Patients | Allergies
Journal Article
American Heart Journal, ISSN 0002-8703, 2013, Volume 165, Issue 6, pp. 854 - 861.e2
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10016, pp. 349 - 356
Journal Article
American Heart Journal, ISSN 0002-8703, 2016, Volume 174, pp. 120 - 128
Dual antiplatelet therapy (DAPT), the combination of aspirin and a P2Y12 inhibitor, given for 12 months remains the standard of care after presentation with... 
Cardiovascular | HIGH-RISK PATIENTS | STENT IMPLANTATION | CARDIAC & CARDIOVASCULAR SYSTEMS | DUAL ANTIPLATELET THERAPY | ANTICOAGULANT-THERAPY | CLINICAL-TRIALS | ACUTE MYOCARDIAL-INFARCTION | DOUBLE-BLIND | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | ACS-TIMI 46 | Prospective Studies | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Adenosine - administration & dosage | Rivaroxaban - administration & dosage | Ticlopidine - analogs & derivatives | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Acute Coronary Syndrome - drug therapy | Dose-Response Relationship, Drug | Young Adult | Adenosine - analogs & derivatives | Platelet Aggregation Inhibitors - administration & dosage | Adolescent | Ticlopidine - administration & dosage | Adult | Female | Drug Therapy, Combination | Stroke (Disease) | Medical research | Aspirin | Atrial fibrillation | Clinical trials | Medicine, Experimental | Anticoagulants (Medicine) | Coronary heart disease | Electrocardiography | Heart attacks | Acute coronary syndromes | Angina pectoris | Human immunodeficiency virus--HIV | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 64, Issue 16, pp. 1708 - 1710
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2011, Volume 161, Issue 2, pp. 261 - 268.e2
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2016, Volume 9, Issue 15, pp. 1576 - 1585
Abstract Objectives This study tested whether intramyocardial (IM) administration of mobilized, purified autologous CD34+ cells would improve total exercise... 
Cardiovascular | interventional therapy | stem cell | angina | angiogenesis | stable coronary disease | CD34 | progenitor cell
Journal Article
Journal Article